Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells and Preclinical AFM28 Data at ASH 2022 Annual Meeting
November 3, 2022
November 3, 2022
November 1, 2022
October 5, 2022
September 5, 2022
September 1, 2022
August 11, 2022
August 4, 2022
June 30, 2022
June 10, 2022
June 1, 2022